André Schrattenholz Selected Research

Annexin A3

1/2009	Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.
12/2008	Expression and prognostic relevance of annexin A3 in prostate cancer.
1/2007	Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André Schrattenholz Research Topics

Disease

6	Neoplasms (Cancer) 01/2010 - 05/2006
4	Schizophrenia (Dementia Praecox) 12/2011 - 05/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2011
3	Parkinson Disease (Parkinson's Disease) 12/2012 - 01/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010 - 01/2007
3	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 01/2007
2	Amyloidosis 01/2014 - 06/2008
2	Breast Neoplasms (Breast Cancer) 01/2007 - 05/2006
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Brain Diseases (Brain Disorder) 12/2011
1	Prostatic Diseases 01/2009
1	Prostatic Intraepithelial Neoplasia 12/2008
1	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 03/2007
1	Ischemia 01/2007
1	Ductal Carcinoma 05/2006
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2006
1	Stroke (Strokes) 01/2006
1	Epilepsy (Aura) 01/2006
1	Neuroinflammatory Diseases 01/2006
1	Wounds and Injuries (Trauma) 01/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2005
1	Hyperhomocysteinemia 05/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2004
3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2007
3	Annexin A3IBA 01/2009 - 01/2007
2	Peptides (Polypeptides)IBA 01/2014 - 06/2008
2	Neuregulin-1 (Neuregulin 1)IBA 12/2012 - 06/2011
2	Protein Isoforms (Isoforms)IBA 12/2011 - 05/2004
2	Pharmaceutical PreparationsIBA 01/2010 - 01/2008
1	EnzymesIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2012
1	Nerve Growth Factors (Neurotrophins)IBA 06/2011
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2009
1	Amyloid beta-PeptidesIBA 06/2008
1	Cytotoxins (Cytolysins)IBA 03/2007
1	Virulence Factors (Pathogenicity Factors)IBA 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	Coenzyme A (CoA)IBA 01/2007
1	CalciumIBA 01/2007
1	isopeptidaseIBA 01/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2006
1	transgelinIBA 05/2006
1	Tamoxifen FDA LinkGeneric 05/2006
1	Cytochromes b5 (Cytochrome b5)IBA 05/2006
1	cellular retinoic acid binding protein IIIBA 05/2006
1	Radioisotopes (Radionuclides)IBA 05/2006
1	Estrogen ReceptorsIBA 05/2006
1	IodineIBA 05/2006
1	Hemoglobins (Hemoglobin)IBA 05/2006
1	CytochromesIBA 05/2006
1	Cyclophilin AIBA 05/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2006
1	GelsIBA 11/2005
1	homocysteic acidIBA 05/2004
1	dihydropyrimidinaseIBA 05/2004
1	14-3-3 Proteins (14-3-3 Protein)IBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2014 - 01/2007
2	Lasers (Laser) 05/2006 - 11/2005